Procsea raised 6.5 M€ in a third round of fundraising
Our portfolio company, PROCSEA, raised 6.5 M€ in a third round of fundraising led by Serena, with additional funding from Cap Horn and existing investors, including FJ Labs, Samaipata Ventures, Piton Capital, SICTIC and Alpana Ventures.
Lunaphore’s CEO on the next generation of cancer treatment
The CEO of our portfolio company LUNAPHORE was interviewed by Ana Maria Montero for CNN Money Switzerland. Ata Tuna Ciftlik explained that every cancer tumor is unique and needs to be treated in a different manner. Watch the video…
